EN #chronic lung disease 9/8/26 AI-Powered Drug Could Reduce Aging Markers A new study published in the journal Nature Biotechnology reveals that the AI-developed drug rentosertib, created by Insilico Medicine, has shown early signs of reducing biological aging markers in a small 12-week trial. Artificial Intelligence News
